NM_001370259.2:c.3G>A

Variant summary

Our verdict is Pathogenic. Variant got 20 ACMG points: 20P and 0B. PVS1PS1_ModeratePM2PP5_Very_Strong

The NM_001370259.2(MEN1):​c.3G>A​(p.Met1?) variant causes a start lost change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: not found (cov: 30)

Consequence

MEN1
NM_001370259.2 start_lost

Scores

7
6
3

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:7

Conservation

PhyloP100: 7.09
Variant links:
Genes affected
MEN1 (HGNC:7010): (menin 1) This gene encodes menin, a tumor suppressor associated with a syndrome known as multiple endocrine neoplasia type 1. Menin is a scaffold protein that functions in histone modification and epigenetic gene regulation. It is thought to regulate several pathways and processes by altering chromatin structure through the modification of histones. [provided by RefSeq, May 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 20 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 154 pathogenic variants. Next in-frame start position is after 228 codons. Genomic position: 64807653. Lost 0.372 part of the original CDS.
PS1
Another start lost variant in NM_001370259.2 (MEN1) was described as [Pathogenic] in Lovd
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 11-64810107-C-T is Pathogenic according to our data. Variant chr11-64810107-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 188376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MEN1NM_001370259.2 linkc.3G>A p.Met1? start_lost Exon 2 of 10 ENST00000450708.7 NP_001357188.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MEN1ENST00000450708.7 linkc.3G>A p.Met1? start_lost Exon 2 of 10 5 NM_001370259.2 ENSP00000394933.3 O00255-2

Frequencies

GnomAD3 genomes
Cov.:
30
GnomAD4 exome
Cov.:
37
GnomAD4 genome
Cov.:
30

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Multiple endocrine neoplasia, type 1 Pathogenic:5
Nov 01, 2016
Center for Human Genetics, Inc, Center for Human Genetics, Inc
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change affects the initiator methionine of the MEN1 mRNA. The next in-frame methionine is located at codon 228. This variant is not present in population databases (gnomAD no frequency). Disruption of the initiator codon has been observed in individuals with multiple endocrine neoplasia type 1 (PMID: 28736585, 29036195; internal data). ClinVar contains an entry for this variant (Variation ID: 188376). For these reasons, this variant has been classified as Pathogenic. -

Mar 03, 2023
Myriad Genetics, Inc.
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered pathogenic. This variant has been reported in multiple individuals with clinical features of gene-specific disease [PMID: 28736585, 35407574, 29036195, 31482957, 36654999, 28329921, 24915123]. -

Sep 07, 2016
Counsyl
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 25, 2021
New York Genome Center
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.3G>A, p.Met1? variant identified in the MEN1 gene has been reported previously in individuals affected with MEN1-related disease (PMID:26767918). This variant affects the initiator methionine of the MEN1 mRNA, and the next in-frame methionine is located at codon 228. The variant is absent in the gnomAD v3.1.1 database, indicating it is an extremely rare allele in the populations represented in this database. Other variants that disrupt the initiator methionine in MEN1 also have been observed in affected individuals with MEN1-related disease (PMID: 28736585, 29036195, 15714081, 26515642). Based on the available evidence, the heterozygous start lost variant c.3G>A, p.Met1? in the MEN1 gene is classified as pathogenic. -

not provided Pathogenic:1
Jul 09, 2020
GeneDx
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Initiation codon variant in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 26767918) -

Hereditary cancer-predisposing syndrome Pathogenic:1
Oct 26, 2016
Ambry Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The p.M1? pathogenic mutation (also known as c.3G>A) is located in coding exon 1 of the MEN1 gene and results from a G to A substitution at nucleotide position 3. This alters the methionine residue at the initiation codon. Since sequence variations that modify the initiation codon (ATG) are expected to result in either loss of translation initiation, N-terminal truncation, or cause a shift in the mRNA reading frame, this alteration is interpreted as a disease-causing mutation. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.62
D
BayesDel_noAF
Pathogenic
0.55
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Benign
0.33
T;.;.;.;.;T;T;T;T;T;.;T;.;.
Eigen
Uncertain
0.58
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.90
D;D;.;.;D;.;.;D;.;D;D;D;.;D
M_CAP
Pathogenic
0.95
D
MetaRNN
Pathogenic
0.94
D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
1.1
D
PROVEAN
Benign
-1.4
N;N;N;N;N;N;N;N;N;N;N;N;N;N
REVEL
Pathogenic
0.88
Sift
Uncertain
0.010
D;D;D;D;D;D;D;D;D;D;D;D;D;D
Sift4G
Pathogenic
0.0
D;D;D;D;D;D;D;D;D;.;D;D;.;.
Polyphen
0.91, 0.93
.;P;P;P;P;P;P;P;P;.;.;.;.;.
Vest4
0.83
MutPred
0.77
Gain of methylation at K4 (P = 0.0458);Gain of methylation at K4 (P = 0.0458);Gain of methylation at K4 (P = 0.0458);Gain of methylation at K4 (P = 0.0458);Gain of methylation at K4 (P = 0.0458);Gain of methylation at K4 (P = 0.0458);Gain of methylation at K4 (P = 0.0458);Gain of methylation at K4 (P = 0.0458);Gain of methylation at K4 (P = 0.0458);Gain of methylation at K4 (P = 0.0458);Gain of methylation at K4 (P = 0.0458);Gain of methylation at K4 (P = 0.0458);Gain of methylation at K4 (P = 0.0458);Gain of methylation at K4 (P = 0.0458);
MVP
0.99
ClinPred
0.99
D
GERP RS
4.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.73
gMVP
0.58

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs786204242; hg19: chr11-64577579; API